Bartlett & CO. Wealth Management LLC trimmed its holdings in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 2.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 106,438 shares of the company’s stock after selling 2,471 shares during the period. Bartlett & CO. Wealth Management LLC’s holdings in Colgate-Palmolive were worth $9,676,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently added to or reduced their stakes in CL. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive during the third quarter worth about $42,000. Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive in the 3rd quarter worth approximately $53,000. Prospera Private Wealth LLC acquired a new position in Colgate-Palmolive in the 3rd quarter worth approximately $64,000. True Wealth Design LLC lifted its position in Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after buying an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC lifted its position in Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after buying an additional 368 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
CL has been the topic of several recent analyst reports. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research report on Thursday, January 16th. Piper Sandler dropped their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Barclays dropped their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Finally, Stifel Nicolaus decreased their price objective on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating for the company in a report on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $101.11.
Insider Buying and Selling at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 0.34% of the stock is currently owned by corporate insiders.
Colgate-Palmolive Stock Down 0.8 %
Shares of CL opened at $87.53 on Thursday. The stock has a market capitalization of $71.51 billion, a price-to-earnings ratio of 25.08, a price-to-earnings-growth ratio of 3.62 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The business’s 50 day simple moving average is $92.07 and its 200-day simple moving average is $97.65. Colgate-Palmolive has a 1 year low of $80.03 and a 1 year high of $109.30.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.28%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- The 3 Best Blue-Chip Stocks to Buy Now
- Oracle Announces Game-Changing News for the AI Industry
- What Are Dividends? Buy the Best Dividend Stocks
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- 3 Best Fintech Stocks for a Portfolio Boost
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.